Recently The Company Announced That It Has Entered Into An Agreement With L And H Resort Systems To Acquire A Former Catskill Mountain Resort Facility Located On A Natural Spring.

Products under the brand include several hemp infused drinks targeting energy drink consumers, relaxation drink consumers, and those interested in bottled water as well. Recently the company announced that it has entered into an agreement with L and H Resort Systems to acquire a former Catskill Mountain resort facility located on a natural spring. Axim Biotech (AXIM) have steadily begun to recover after “the great marijuana stock pull-back.” At one point the stock was trading as high as $19.80 and ended up consolidating to as marijuana low as $8.01 in February. The company’s flagship products include CanChew, which is a CBD-based chewing gum, and MedChew Rx, a combination CBD/THC gum that is undergoing clinical trials for the treatment of pain and spasticity that deal with multiple sclerosis. In recent news, Axim announced that it has retained a contract research organization, Ora, Inc., to take care of the company’s pending product development and clinical trials for the treatment of glaucoma and dry eye. The company will be utilizing cannabinoid-based therapeutics. Since trading around $0.025 in September, mCig, Inc. (MCIG) has managed to reach highs of $0.505 within the last few months but yet again, as with many other stocks in the sector, shares have pulled back in price and recent trading has seen the trend as more sideways than anything. The stock has been upholding a channel roughly between $0.200 and $0.30 for the last few weeks. The company most recently announced that it has been selected to be the builder of choice of the first large scale indoor grow facility in Oregon for Forest Grove Cultivation.

To read more visit

Comments are closed.